Literature DB >> 3311456

Elevated pulmonary vascular resistance and cardiac transplantation.

L J Addonizio1, W M Gersony, R C Robbins, R E Drusin, C R Smith, D S Reison, K Reemtsma, E A Rose.   

Abstract

Severe elevation of pulmonary vascular resistance has been considered a contraindication to cardiac transplantation. Most centers exclude patients with pulmonary vascular resistance greater than 6 Wood units. Wood units, however, do not correct for variations in body size and therefore may not be the best measure for use in comparison of patients. We performed a retrospective analysis of 82 cardiac transplant recipients and compared preoperative pulmonary vascular resistance (PVR) calculated in two ways to the incidence of right ventricular failure and death. Our data show that the PVR index unit (PVRI) identifies those patients that are at risk for right heart failure better than the Wood unit, which does not correct for body size. Four patients died of right heart failure with resistance less than 6 Wood units, but had PVRI greater than 6 units. High resistance is not an absolute contraindication to cardiac transplantation; 28 of 33 patients operated on with a PVRI greater than 6 survived. The degree of elevation of PVR did not correlate with survival. Ten of 12 patients with a PVRI greater than 9 survived. Testing with nitroprusside at cardiac catheterization was helpful in determining reversibility of pulmonary vascular obstruction. No patients with a PVRI less than 6 developed right heart failure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311456

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  [Perioperative implications of heart transplant].

Authors:  H K Eltzschig; B Zwissler; T W Felbinger
Journal:  Anaesthesist       Date:  2003-08       Impact factor: 1.041

2.  The author replies.

Authors:  J N Graziano
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.655

Review 3.  Right heart catheterization and risk stratification in advanced heart failure.

Authors:  Michael Craig; Naveen L Pereira
Journal:  Curr Heart Fail Rep       Date:  2006-09

Review 4.  State of the Art of Combined Heart-Lung Transplantation for Advanced Cardiac and Pulmonary Dysfunction.

Authors:  Jay J Idrees; Gösta B Pettersson
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

5.  Heart Transplantation in Children With Down Syndrome.

Authors:  Justin Godown; Darlene Fountain; Neha Bansal; Rebecca Ameduri; Susan Anderson; Gary Beasley; Danielle Burstein; Kenneth Knecht; Kimberly Molina; Sherry Pye; Marc Richmond; Joseph A Spinner; Kae Watanabe; Shawn West; Zdenka Reinhardt; Janet Scheel; Simon Urschel; Chet Villa; Seth A Hollander
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

6.  Initial Experience with Sildenafil, Bosentan, and Nitric Oxide for Pediatric Cardiomyopathy Patients with Elevated Pulmonary Vascular Resistance before and after Orthotopic Heart Transplantation.

Authors:  Babak Daftari; Juan Carlos Alejos; Gregory Perens
Journal:  J Transplant       Date:  2010-03-10

7.  Left ventricular assist device to avoid heart-lung transplant in an adolescent with dilated cardiomyopathy and severely elevated pulmonary vascular resistance.

Authors:  Betul Yilmaz; Warren A Zuckerman; Teresa M Lee; Kimberly D Beddows; Lisa A Gilmore; Rakesh K Singh; Marc E Richmond; Jonathan M Chen; Linda J Addonizio
Journal:  Pediatr Transplant       Date:  2013-05-26

8.  Can the infusion of isotonic fluids or vasopressors prevent hemodynamic changes in cardiac surgery patients?

Authors:  Mahmoud Saiedi; Minoo Movahedi; Mojgan Gharipour
Journal:  ARYA Atheroscler       Date:  2012

Review 9.  Postoperative care of the transplanted patient.

Authors:  Kurt R Schumacher; Robert J Gajarski
Journal:  Curr Cardiol Rev       Date:  2011-05

10.  Inhaled nitric oxide applications in paediatric practice.

Authors:  A Bernasconi; M Beghetti
Journal:  Images Paediatr Cardiol       Date:  2002-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.